当前位置: 首页 >> 检索结果
共有 62504 条符合本次的查询结果, 用时 3.0348357 秒

1301. Aortic Valve Calcification: Clarifying Severity and Prognosis in Low-Flow Aortic Stenosis.

作者: Bassim El-Sabawi.;Brian R Lindman.
来源: Circ Cardiovasc Imaging. 2025年18卷1期e017855页

1302. How to Use Imaging: Complex Cases of Atherosclerosis, Myocardial Inflammation, and Cardiomyopathy in Cardio-Oncology.

作者: Mohamad Khattab.;Mariam Baig.;Talal El Zarif.;Ana Barac.;Maros Ferencik.;Mariana L Henry.;Juan Lopez-Mattei.;Alban Redheuil.;Joe-Elie Salem.;Marielle Scherrer-Crosbie.;Eric H Yang.;Lauren A Baldassarre.
来源: Circ Cardiovasc Imaging. 2025年18卷1期e015981页
It is well understood that cancer therapies including chemotherapy, tyrosine kinase inhibitors, immune checkpoint inhibitors, and radiation can increase the risk of cardiovascular disease in patients with cancer. This can manifest as a multitude of pathologies including left ventricular dysfunction, myocarditis, cardiomyopathy, accelerated atherosclerosis, and coronary vasospasm. Multimodal cardiac imaging plays a critical role in diagnosing such pathologies by relying on noninvasive tools including echocardiograms, cardiac magnetic resonance imaging, positron emission tomography, single-photon emission computed tomography, and coronary computed tomography angiography. These methods have unique considerations and in recent years have made significant progress in their diagnostic capabilities in this patient population. As the field of cardio-oncology continues to expand rapidly, guidance on the management of such toxicities and the development of imaging technologies is crucial. In this review, we present 2 complex cases of atherosclerosis and myocarditis in patients with cancer, highlighting our rationale for management and discussing the nuances of various cardiac imaging modalities.

1303. Early Evolution of SCAI Shock Stage and In-Hospital Mortality in the Cardiovascular Intensive Care Unit Population: From the Critical Care Cardiology Trials Network (CCCTN).

作者: Stephanie Skove.;David D Berg.;Erin A Bohula.;Jianping Guo.;Carlos E Alfonso.;Gregory W Barsness.;James A Burke.;Meshe D Chonde.;Jacob C Jentzer.;Jason N Katz.;Michael C Kontos.;Younghoon Kwon.;Patrick R Lawler.;Shuangbo Liu.;P Elliott Miller.;Connor G O'Brien.;Alexander I Papolos.;Alastair G Proudfoot.;Kiran Sidhu.;Shashank S Sinha.;Lakshmi Sridharan.;Jeffrey J Teuteberg.;Sean van Diepen.;Sammy Zakaria.;David A Morrow.;Kevin S Shah.
来源: Circ Heart Fail. 2025年18卷2期e012109页

1304. Comprehensive Non-invasive Versus Invasive Approach to Evaluate Cardiac Allograft Vasculopathy in Heart Transplantation: The CCTA-HTx Study.

作者: Marta Belmonte.;Pasquale Paolisso.;Michele Mattia Viscusi.;Monika Beles.;Luca Bergamaschi.;Angelo Sansonetti.;Hirofumi Ohashi.;Ruiko Seki.;Emanuele Gallinoro.;Giuseppe Esposito.;Monika Shumkova.;Attilio Leone.;Marco Masetti.;Emanuele Barbato.;Sofie Verstreken.;Riet Dierckx.;Ward Heggermont.;Jan Van Keer.;Luciano Potena.;Carmine Pizzi.;Jozeph Bartunek.;Marc Vanderheyden.
来源: Circ Cardiovasc Imaging. 2025年18卷1期e017197页
Coronary computed tomography angiography (CCTA) is emerging as a valuable tool for noninvasive surveillance of cardiac allograft vasculopathy (CAV) in patients with heart transplant (HTx). We assessed the diagnostic performance of a comprehensive CCTA-based approach compared with the invasive reference, which includes invasive coronary angiography, intravascular ultrasound, and fractional flow reserve, for detecting CAV.

1305. Finding the Arrhythmic Needle in the Low-Risk Haystack: Heritability of Imaging Features of Arrhythmic Mitral Valve Prolapse.

作者: Susan K Keen.;Deborah H Kwon.
来源: Circ Cardiovasc Imaging. 2025年18卷1期e017854页

1306. Contemporary Approach to Cardiac Allograft Vasculopathy Surveillance: The Role of Coronary CT Angiography.

作者: Haya Aziz.;Adam D DeVore.;Melissa A Daubert.
来源: Circ Cardiovasc Imaging. 2025年18卷1期e017787页

1307. Inheritance of Imaging Parameters of Arrhythmic Risk in Mitral Valve Prolapse: A Pedigree Study.

作者: Luca Cristin.;Shalini Dixit.;Dwight Bibby.;Janet J Tang.;Qizhi Fang.;Lionel Tastet.;Amy H Rich.;Rohit Jhawar.;Yasufumi Nagata.;Satoshi Higuchi.;Robert A Levine.;Henry H Hsia.;Zian H Tseng.;Nelson B Schiller.;Francesca N Delling.
来源: Circ Cardiovasc Imaging. 2025年18卷1期e017051页
A subset of patients with mitral valve prolapse (MVP), a highly heritable condition, experience sudden cardiac arrest (SCA) or sudden cardiac death (SCD). However, the inheritance of phenotypic imaging features of arrhythmic MVP remains unknown.

1308. Empirical Non-Pulmonary Vein Trigger Ablation for Management of Atrial Fibrillation: Is Cryoballoon Isolation of the Superior Vena Cava the Answer?

作者: Fatima M Ezzeddine.;Yong-Mei Cha.
来源: Circ Arrhythm Electrophysiol. 2025年18卷1期e013637页

1309. Personalized Heart Digital Twins Detect Substrate Abnormalities in Scar-Dependent Ventricular Tachycardia.

作者: Michael C Waight.;Adityo Prakosa.;Anthony C Li.;Nick Bunce.;Anna Marciniak.;Natalia A Trayanova.;Magdi M Saba.
来源: Circulation. 2025年151卷8期521-533页
Current outcomes from catheter ablation for scar-dependent ventricular tachycardia (VT) are limited by high recurrence rates and long procedure durations. Personalized heart digital twin technology presents a noninvasive method of predicting critical substrate in VT, and its integration into clinical VT ablation offers a promising solution. The accuracy of the predictions of digital twins to detect invasive substrate abnormalities is unknown. We present the first prospective analysis of digital twin technology in predicting critical substrate abnormalities in VT.

1310. Patient Empowerment in the Management of Atrial Fibrillation: The Missing Link for Improved Outcomes.

作者: Ratika Parkash.
来源: Circ Arrhythm Electrophysiol. 2025年18卷1期e013638页

1311. Racial, Socioeconomic, and Geographic Disparities in Preamputation Vascular Care for Patients With Chronic Limb-Threatening Ischemia.

作者: Omar I Ramadan.;Lin Yang.;Kaitlyn Shultz.;Elizabeth Genovese.;Scott M Damrauer.;Grace J Wang.;Eric A Secemsky.;Diane J Treat-Jacobson.;Robin J Womeodu.;Foluso A Fakorede.;Ashwin S Nathan.;Lauren A Eberly.;Howard M Julien.;Taisei J Kobayashi.;Peter W Groeneveld.;Jay Giri.;Alexander C Fanaroff.
来源: Circ Cardiovasc Qual Outcomes. 2025年18卷1期e010931页
Black patients, those with low socioeconomic status (SES), and those living in rural areas have elevated rates of major lower extremity amputation, which may be related to a lack of subspecialty chronic limb-threatening ischemia care. We evaluated the association between race, rurality, SES, and preamputation vascular care.

1312. Evaluation of Peer Review of Percutaneous Coronary Intervention Operator Performance.

作者: Jacob A Doll.;Annika L Hebbe.;Carol E Simons.;Elliot J Stein.;Stephan Eisenbarth.;Stephen W Waldo.;Sunil V Rao.;David H Au.
来源: Circ Cardiovasc Qual Outcomes. 2025年18卷1期e011159页
Case-based peer review of percutaneous coronary intervention (PCI) is used by many hospitals for quality improvement and to make decisions regarding physician competency. However, there are no studies testing the reliability or validity of peer review for PCI performance evaluation.

1313. Looking for Peers for Procedural Peer Review: A Paradigm to Improve Patient Outcomes.

作者: Eric P Cantey.;Brett L Wanamaker.;John A Bittl.
来源: Circ Cardiovasc Qual Outcomes. 2025年18卷1期e011728页

1314. Utilization and Outcomes Associated With Intravascular Ultrasound During Abdominal and Thoracic Endovascular Aortic Interventions in the United States in the Contemporary Era (2016-2023).

作者: Ramya C Mosarla.;Patrick V Heindel.;Mohamad A Hussain.;Marc Schermerhorn.;Toshiki Kuno.;Mario D'Oria.;Siling Li.;Eric A Secemsky.
来源: Circ Cardiovasc Interv. 2025年18卷1期e014332页
Intravascular ultrasound (IVUS) use in aortic endovascular interventions, including thoracic endovascular aneurysm repair (TEVAR) and endovascular aneurysm repair (EVAR), may have similar benefits to those seen in coronary and peripheral interventions, but limited utilization and outcome data exist.

1315. Extended Rhythm Monitoring to Assess for Ventricular Arrhythmias After Transcatheter Pulmonary Valve Replacement With the Harmony Valve.

作者: Jeffrey K Yang.;Laura Wattenbarger.;Anne C Taylor.;Henry Chubb.;Anitra W Romfh.;Lynn F Peng.;Scott R Ceresnak.;Anne M Dubin.;Doff B McElhinney.
来源: Circ Cardiovasc Interv. 2025年18卷1期e014381页
Varying rates of nonsustained ventricular tachycardia (NSVT) have been reported early after transcatheter pulmonary valve replacement (TPVR) with the Harmony valve, but data regarding rhythm outcomes beyond hospital discharge are limited. This study aims to characterize ventricular arrhythmias after Harmony TPVR from implant through mid-term follow-up.

1316. Impact of Bifurcation Lesions on Outcomes After FFR-Guided PCI or CABG.

作者: Daimy M M Dillen.;Hisao Otsuki.;Kuniaki Takahashi.;Yuhei Kobayashi.;Zsolt Piroth.;Nicolas Noiseux.;Badih El Nakadi.;Gintaras Kalinauskas.;Laszlo Szekely.;Giedrius Davidavičius.;Koen Teeuwen.;Pim A L Tonino.;Nico H J Pijls.;Bernard De Bruyne.;William F Fearon.;Frederik M Zimmermann.
来源: Circ Cardiovasc Interv. 2025年18卷1期e014610页
In the era of first-generation drug-eluting stents and angiography-guided percutaneous coronary intervention (PCI), the presence of a bifurcation lesion was associated with adverse outcomes after PCI. In contrast, the presence of a bifurcation lesion had no impact on outcomes following coronary artery bypass grafting (CABG). Therefore, the presence of a coronary bifurcation lesion requires special attention when choosing between CABG and PCI. The aim of this study is to assess whether the presence of a bifurcation lesion still influences clinical outcomes after contemporary PCI using second-generation drug-eluting stent and fractional flow reserve (FFR) guidance versus CABG.

1317. Referral Networks, Racial Inequity, and Hospital Quality for Open Heart Surgery.

作者: C Ben Gibson.;Cheryl L Damberg.;Jose J Escarce.;Shiyuan Zhang.;Megan S Schuler.;Luke J Matthews.;Ioana Popescu.
来源: Circ Cardiovasc Qual Outcomes. 2025年18卷1期e010778页
Differences in the quality of hospitals where Black and White patients receive coronary artery bypass grafting (CABG) surgery have been documented. We examined the contributions of physician networks to the gap.

1318. Real-Time Pressure-Volume Loop Assessment of Left Ventricular Performance to Evaluate Suitability for Repair in Congenitally Corrected Transposition of the Great Arteries.

作者: Kyong-Jin Lee.;Kaitlin Flannery.;Michael Ma.;Deborah Ho.
来源: Circ Heart Fail. 2025年18卷2期e012609页

1319. Spotlight on YAP: Unlocking New Insights to Overcome the Barriers to Heart Regeneration.

作者: Nivedhitha Velayutham.;Richard T Lee.
来源: Circulation. 2025年151卷1期94-97页
This editorial refers to “Microtubules Sequester Acetylated YAP in the Cytoplasm and Inhibit Heart Regeneration” by Liu et al. and “YAP Overcomes Mechanical Barriers to Induce Mitotic Rounding and Adult Cardiomyocyte Division” by Morikawa et al.

1320. 40th Anniversary of the TIMI Study Group.

作者: Marc S Sabatine.;Eugene Braunwald.
来源: Circulation. 2025年151卷1期4-7页
共有 62504 条符合本次的查询结果, 用时 3.0348357 秒